Next Capital Management’s Amedisys AMED Stock Holding History

Next Capital Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-85	Closed	-$10K	–	279
2019 Q2	$10K	Buy	+85	New	+$10.1K	0.01%	433

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Next Capital Management's AMED Position: Q3 2019 in Review

Next Capital Management sold out of Amedisys (AMED) in Q3 2019, closing a stake of 85 shares — an estimated $10K sold.

Next Capital Management first reported a position in AMED in Q2 2019 and held it in 1 quarter. The position peaked at $10K in Q2 2019. 283 funds tracked by Wall St. Rank hold AMED as of Q3 2019.

Next Capital Management reported no remaining Amedisys position as of Q3 2019 after selling out during the quarter.
Next Capital Management sold 85 Amedisys shares in Q3 2019, an estimated $10K.
Next Capital Management first reported a position in Amedisys in Q2 2019 and held it in 1 quarter.
Next Capital Management's Amedisys position peaked at $10K in Q2 2019.
283 funds tracked by Wall St. Rank held Amedisys as of Q3 2019.

Based on Next Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.